Market revenue in 2023 | USD 350.9 million |
Market revenue in 2030 | USD 483.8 million |
Growth rate | 4.7% (CAGR from 2023 to 2030) |
Largest segment | Soil-transmitted helminthiases |
Fastest growing segment | Chagas disease |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Dengue, Chikungunya, Rabies, Leprosy, Buruli ulcer, Yaws, Lymphatic Filariasis, Taeniasis/Cysticercosis, Foodborne Trematode Infections, Echinococcosis, Chagas disease, Dracunculiasis, Human African Trypanosomiasis (sleeping sickness), Soil-transmitted Helminthiases, Onchocerciasis, Schistosomiasis, Scabies and Other Ecoparasites, Snakebite Envenoming, Leishmaniases |
Key market players worldwide | Roche, Abbott Laboratories, Thermo Fisher Scientific Inc, Eurobio-Scientific, Omega Laboratories, Avacta Group PLC, Oscar Health Inc Class A, ZeptoMetrix, InBios, DiaSys Diagnostic Systems |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to neglected tropical diseases diagnosis market will help companies and investors design strategic landscapes.
Soil-transmitted helminthiases was the largest segment with a revenue share of 9.69% in 2023. Horizon Databook has segmented the India neglected tropical diseases diagnosis market based on dengue, chikungunya, rabies, leprosy, buruli ulcer, yaws, lymphatic filariasis, taeniasis/cysticercosis, foodborne trematode infections, echinococcosis, chagas disease, dracunculiasis, human african trypanosomiasis (sleeping sickness), soil-transmitted helminthiases, onchocerciasis, schistosomiasis, scabies and other ecoparasites, snakebite envenoming, leishmaniases covering the revenue growth of each sub-segment from 2018 to 2030.
India neglected tropical diseases diagnosis market is expected to witness significant growth due to increase in investments by private & foreign entities, rise in consumer awareness, and increase in the prevalence of NTDs.
It is the second-most populated country globally; thus, there is a larger pool of patients suffering from NTDs. Hence, there is substantial presence of global players in the country.
Consumer awareness and high disease prevalence have led to increase in the number of tests and diagnostics for NTDs in the past few years. According to March 2018 NCBI article, India accounted for around half of the world’s prevalent cases of visceral leishmaniasis.
Horizon Databook provides a detailed overview of country-level data and insights on the India neglected tropical diseases diagnosis market , including forecasts for subscribers. This country databook contains high-level insights into India neglected tropical diseases diagnosis market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account